Scientific Publications
-
Langer R., Brown L., Edelman E., Kost J., and Fischel-Ghodsian F., “Controlled release and magnetically modulated release of polypeptides: Recent advances”. Controlled Release Society Meeting, Geneva, Switzerland, July 1985.
-
Langer R., Kost J., Fischel-Ghodsian F., Brown L., and Leong K., “ Regulation of controlled release by ultrasound or enzyme”, 191st American Chemical Society National Meeting, New York, April 1986.
-
Fischel-Ghodsian F., Jacobs O.L.R. and Langer R., “Glucose-dependent insulin delivery system", Meeting of The Society for Drug Research and Advances in Drug Delivery, Cambridge, U.K., July 1986.
-
Fischel-Ghodsian F., Brown L., Mathiowitz E., Brandenburg D., and Langer R., “Enzymatically controlled drug delivery”, Proceedings of the National Academy of Sciences USA, Vol. 85., p. 2403-2406, 1988.
-
Fischel-Ghodsian F., Brown L., and Langer R., “ Solubility-dependent controlled release systems”, In “Pulsed and self-regulated drug delivery”, Kost J. Ed., CRC Press, Boca Raton, FL., p. 201-212, 1990.
-
Fischel Ghodsian F., Mathiowitz G., and Smith T.F., “Alignment of protein sequences using secondary structure: a modified dynamic programming method”, Protein Engineering; Vol.3, p. 557-581, 1990.
-
Fischel-Ghodsian F. and Newton J.M. “Modeling of insulin release from a glucose-responsive degradable polymeric system”, Journal of Membrane Science; Vol. 48, p.33-45, 1990.
-
Fischel-Ghodsian F. and Newton J.M. “Simulation and optimization of a self-regulating insulin delivery system”, Journal of Drug Targeting; Vol. 1 p.67-80, 1993.
-
Fischel-Ghodsian F. and Newton J.M. “Analysis of drug release kinetics from degradable polymeric device”, Journal of Drug Targeting; Vol. 1 p. 51-57, 1993.
-
Brown L., Edelman E., Fischel-Ghodsian F. and Langer L., “Characterization of glucose-mediated insulin release from implanted polymer", Journal of Pharmaceutical Sciences, Vol. 85 (12), p 1341-1345, 1996.
Financial Publications
-
“Annual Wall Street Roundup”, Genetic Engineering News; Vol. 15 (2), p.9, 1995.
-
“Commentary on Wall Street – Acquisition as a best-scenario”, Bio/Technology; Vol. 13, p. 426, May 1995.
-
“Commentary on Wall Street – In all, Wall Street supports biotech acquisitions”, Bio/Technology; Vol. 13, p. 729, Aug 1995.
-
“Building Valuation models –The conjurer’s art”, BioCentury; Vol.3 (73), p. A4, Oct. 1995.
-
“Creative financing of biotechnology ventures”, Biomedical Synergies; Vol. 1(2), p.11, 1995.
-
“Commentary on Wall Street – Technology: A safety net for high-wire acts”, Bio/Technology; Vol. 13, p. 1154, Nov. 1995.
-
“Annual Wall Street Roundup”. Genetic Engineering News; Vol. 15 (2), p.8, 1996.
-
“Annual Wall Street Roundup”, Genetic Engineering News; February 2000.
-
Outlook for Biotechnology Stocks, The Wall Street Transcript, February 2001.
-
HIV/AIDS Biotech and Pharma Global Conference, Diplomatic Planet Q&A Presentation, New York, NY, June 2001.
-
Focus on Analyst, Wall Street Research, p.29, November 2001.
-
Biotech Success, Healthcare Research Team Profile, Buy Side; Vol. 8 (10), p.95-97, Winter 2001.
-
Outlook for Biotechnology, The Wall Street Transcript, February 2002.
-
Roundtable Forum - Biotechnology, along with other biotechnology analyst from J.P.Morgan Chase, Lehman Brothers, FBR and AG Edwards, The Wall Street Transcript, Vol. CLVII, Number 2, July 8, 2002.
-
Where are the Opportunities in the Biotech Sector Now, Roundtable forum along with other biotechnology analysts, CEOs and fund managers. Wall Street Reporter, July 31 2002, Focus Report.
-
Analyst Interview: Funding Biotech Companies, The Wall Street Transcript, October 14, 2002.
-
Money Manager Interview: A Healthy Hedge, Buyside, March 2003.
-
"She Blinded Me With Science: Investing in Biotech". Chapter 5 in the book by Meredith A. Jones "Women of the Street - Why Female Money Managers Generate Higher Returns (And How You Can Too)", April 2015.
-
"Sector Commentary", Quarterly Data Report: Regenerative Medicine & Advanced Therapies, October 2015.
DAFNA Capital Management LLC | 10990 Wilshire Boulevard, Suite 1400 | Los Angeles, CA 90024 | Contact Us | p: 310.954.3200
Please review our Disclaimers and Important Legal Information
© 2022, DAFNA Capital Management, LLC